AddLife Management

Management criteria checks 2/4

AddLife's CEO is Fredrik Dalborg, appointed in Jan 2022, has a tenure of 2.25 years. total yearly compensation is SEK8.70M, comprised of 56.8% salary and 43.2% bonuses, including company stock and options. directly owns 0.02% of the company’s shares, worth SEK2.50M. The average tenure of the management team and the board of directors is 0.7 years and 8.6 years respectively.

Key information

Fredrik Dalborg

Chief executive officer

kr8.7m

Total compensation

CEO salary percentage	56.8%
CEO tenure	2.3yrs
CEO ownership	0.02%
Management average tenure	less than a year
Board average tenure	8.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Fredrik Dalborg's remuneration changed compared to AddLife's earnings?
Date	Total Compensation	Salary	Company Earnings
Mar 31 2024	n/a	n/a	kr78m
Dec 31 2023	kr9m	kr5m	kr190m
Sep 30 2023	n/a	n/a	kr293m
Jun 30 2023	n/a	n/a	kr388m
Mar 31 2023	n/a	n/a	kr429m
Dec 31 2022	kr6m	kr2m	kr480m

Compensation vs Market: Fredrik's total compensation ($USD796.47K) is below average for companies of similar size in the UK market ($USD1.33M).

Compensation vs Earnings: Fredrik's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Fredrik Dalborg (51 yo)

2.3yrs

Tenure

kr8,704,000

Compensation

Mr. Fredrik Dalborg serves as President & Chief Executive Officer at AddLife AB (publ) since 2022. Mr. Dalborg served as Managing Director for North America at Xvivo Perfusion AB (publ) since December 15,...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Fredrik Dalborg	President & CEO	2.3yrs	kr8.70m	0.020% SEK 2.5m
Christina Rubenhag	Chief Financial Officer	2.3yrs	no data	0.0033% SEK 409.3k
Julie O'Leary	Investor Relations Manager	less than a year	no data	no data
Christian Karlsson	Head of Business Development	3.3yrs	no data	no data
Per Wahlstedt	Head of Business Control	2.3yrs	no data	no data
Timmy Rosendal	Head of Sustainability	less than a year	no data	no data
Ioana Dragan	Head of Financial Control	less than a year	no data	no data
Jamilah Wass	Group Financial Controller	no data	no data	no data
Nichlas Essner	Group Business Controller	less than a year	no data	no data
Malin Lindh	Group Business Controller	less than a year	no data	no data

0.7yrs

Average Tenure

Experienced Management: 0REZ's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.

Board Members

Name	Position	Tenure	Compensation	Ownership
Birgit Norinder	Independent Director	8.6yrs	kr350.00k	0.010% SEK 1.3m
Eva Elmstedt	Independent Director	2.9yrs	kr350.00k	0.0041% SEK 511.6k
Johan Sjo	Independent Chairman	9.1yrs	kr700.00k	0.14% SEK 16.9m
Håkan Roos	Independent Director	8.8yrs	kr350.00k	4.75% SEK 593.1m
Eva Nilsagard	Independent Director	8.3yrs	kr500.00k	0.0046% SEK 570.3k
Stefan Hedelius	Independent Director	8.6yrs	kr350.00k	0.024% SEK 3.0m

8.6yrs

Average Tenure

61yo

Average Age

Experienced Board: 0REZ's board of directors are considered experienced (8.6 years average tenure).

AddLife Management

Management criteria checks 2/4

Key information

Recent management updates

Independent Director recently bought kr207k worth of stock

Independent Director recently bought kr32m worth of stock

President & CEO recently bought kr220k worth of stock

Independent Director recently bought kr521k worth of stock

Chief Financial Officer recently bought kr143k worth of stock

AddLife AB (publ), Annual General Meeting, May 08, 2024

Recent updates

First quarter 2024 earnings released: EPS: kr0.51 (vs kr1.43 in 1Q 2023)

AddLife AB (publ) to Report Fiscal Year 2024 Results on Feb 05, 2025

Independent Director recently bought kr207k worth of stock

Independent Director recently bought kr32m worth of stock

AddLife AB (publ) to Report Fiscal Year 2023 Results on Apr 05, 2024

Dividend of kr0.50 announced

President & CEO recently bought kr220k worth of stock

Full year 2023 earnings released: EPS: kr1.56 (vs kr3.94 in FY 2022)

AddLife AB (publ) to Report Q3, 2024 Results on Oct 23, 2024

Independent Director recently bought kr521k worth of stock

Investor sentiment improves as stock rises 32%

Chief Financial Officer recently bought kr143k worth of stock

AddLife AB (publ) to Report First Half, 2024 Results on Jul 15, 2024

Third quarter 2023 earnings released

AddLife AB (publ), Annual General Meeting, May 08, 2024

Independent Director recently bought kr581k worth of stock

President & CEO recently bought kr208k worth of stock

Independent Chairman recently bought kr1.3m worth of stock

Investor sentiment deteriorates as stock falls 31%

Second quarter 2023 earnings released: EPS: kr0.27 (vs kr0.61 in 2Q 2022)

Now 22% undervalued

Independent Director recently bought kr12m worth of stock

President & CEO recently bought kr129k worth of stock

Addlife AB (Publ) Declares Dividend

Upcoming dividend of kr1.20 per share at 1.0% yield

First quarter 2023 earnings released

Investor sentiment improves as stock rises 15%

President & CEO recently bought kr139k worth of stock

President & CEO recently bought kr112k worth of stock

Full year 2022 earnings released: EPS: kr3.94 (vs kr6.02 in FY 2021)

AddLife AB (publ) Proposes Dividend for the Year Ended December 31, 2022

Investor sentiment improves as stock rises 18%

President & CEO recently bought kr285k worth of stock

Investor sentiment improved over the past week

Håkan Roos acquired a 0.246285% stake in AddLife AB (publ) for SEK 30 million.

Third quarter 2022 earnings released

AddLife AB (publ) to Report First Half, 2023 Results on Jul 14, 2023

AddLife AB (publ) to Report Q1, 2023 Results on Apr 26, 2023

Now 20% undervalued after recent price drop

Investor sentiment improved over the past week

Second quarter 2022 earnings released

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

Investor sentiment deteriorated over the past week

CFO & Business Area Manager of Medtech recently sold kr8.5m worth of stock

Investor sentiment improved over the past week

Addlife AB (Publ) Approves Dividend, Payable on 12 May 2022

Upcoming dividend of kr2.00 per share

AddLife AB (publ) Appoints Fredrik Dalborg as President

Full year 2021 earnings released: EPS: kr6.02 (vs kr4.62 in FY 2020)

AddLife AB (publ) (OM: ALIF B) acquired O'Flynn Medical Limited.

Addlife AB (Publ) Proposes Dividend, Payable on 12 May 2022

AddLife AB (publ) (OM:ALIF B) completed the acqusitions of Telia Health Monitoring.

President & CEO recently bought kr5.8m worth of stock

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Addlife AB (Publ) Proposes Dividend

Addlife AB (Publ) Announces Step Down of Kristina Willgård as Chief Executive Officer

AddLife AB (publ) (OM:ALIF B) completed the acquisition of MBA Incorporado S.A from Alantra Private Equity.

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire MBA Incorporado S.A from Alantra Private Equity for approximately €110 million.

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Telia Health Monitoring.

Beijing AddLife AB (publ) (OM:ALIF B) acquired Camanio AB from Brighter AB (publ) (OM:BRIG) for SEK 65 million.

President & CEO recently sold kr32m worth of stock

Third quarter 2021 earnings released

Investor sentiment deteriorated over the past week

Independent Chairman recently sold kr11m worth of stock

AddLife AB (publ) (OM:ALIF B) acquired Bio-Connect BV.